These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 22465187

  • 1. Striatal NMDA receptors gate cortico-pallidal synchronization in a rat model of Parkinson's disease.
    Zold CL, Escande MV, Pomata PE, Riquelme LA, Murer MG.
    Neurobiol Dis; 2012 Jul; 47(1):38-48. PubMed ID: 22465187
    [Abstract] [Full Text] [Related]

  • 2. Striatal gating through up states and oscillations in the basal ganglia: Implications for Parkinson's disease.
    Zold CL, Kasanetz F, Pomata PE, Belluscio MA, Escande MV, Galinanes GL, Riquelme LA, Murer MG.
    J Physiol Paris; 2012 Jan; 106(1-2):40-6. PubMed ID: 21767642
    [Abstract] [Full Text] [Related]

  • 3. NR2A and NR2B subunit containing NMDA receptors differentially regulate striatal output pathways.
    Fantin M, Marti M, Auberson YP, Morari M.
    J Neurochem; 2007 Dec; 103(6):2200-11. PubMed ID: 17986236
    [Abstract] [Full Text] [Related]

  • 4. Functional imaging of cognition in Parkinson's disease.
    Carbon M, Marié RM.
    Curr Opin Neurol; 2003 Aug; 16(4):475-80. PubMed ID: 12869806
    [Abstract] [Full Text] [Related]

  • 5. Loss of the preferential control over the striato-nigral direct pathway by striatal NMDA receptors in a rat model of Parkinson's disease.
    Morari M, Fantin M.
    Analyst; 2015 Jun 07; 140(11):3830-9. PubMed ID: 25584655
    [Abstract] [Full Text] [Related]

  • 6. Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms.
    Giorgi M, D'Angelo V, Esposito Z, Nuccetelli V, Sorge R, Martorana A, Stefani A, Bernardi G, Sancesario G.
    Eur J Neurosci; 2008 Sep 07; 28(5):941-50. PubMed ID: 18717735
    [Abstract] [Full Text] [Related]

  • 7. Striatal NTS1 , dopamine D2 and NMDA receptor regulation of pallidal GABA and glutamate release--a dual-probe microdialysis study in the intranigral 6-hydroxydopamine unilaterally lesioned rat.
    Ferraro L, O'Connor WT, Beggiato S, Tomasini MC, Fuxe K, Tanganelli S, Antonelli T.
    Eur J Neurosci; 2012 Jan 07; 35(2):207-20. PubMed ID: 22211865
    [Abstract] [Full Text] [Related]

  • 8. Fos expression following activation of the ventral pallidum in normal rats and in a model of Parkinson's Disease: implications for limbic system and basal ganglia interactions.
    Turner MS, Gray TS, Mickiewicz AL, Napier TC.
    Brain Struct Funct; 2008 Sep 07; 213(1-2):197-213. PubMed ID: 18663473
    [Abstract] [Full Text] [Related]

  • 9. Computational physiology of the basal ganglia in Parkinson's disease.
    Rivlin-Etzion M, Elias S, Heimer G, Bergman H.
    Prog Brain Res; 2010 Sep 07; 183():259-73. PubMed ID: 20696324
    [Abstract] [Full Text] [Related]

  • 10. A direct relationship between oscillatory subthalamic nucleus-cortex coupling and rest tremor in Parkinson's disease.
    Hirschmann J, Hartmann CJ, Butz M, Hoogenboom N, Ozkurt TE, Elben S, Vesper J, Wojtecki L, Schnitzler A.
    Brain; 2013 Dec 07; 136(Pt 12):3659-70. PubMed ID: 24154618
    [Abstract] [Full Text] [Related]

  • 11. Differential effect of NR2A and NR2B subunit selective NMDA receptor antagonists on striato-pallidal neurons: relationship to motor response in the 6-hydroxydopamine model of parkinsonism.
    Fantin M, Auberson YP, Morari M.
    J Neurochem; 2008 Jul 07; 106(2):957-68. PubMed ID: 18435828
    [Abstract] [Full Text] [Related]

  • 12. Subthalamo-pallidal interactions underlying parkinsonian neuronal oscillations in the primate basal ganglia.
    Tachibana Y, Iwamuro H, Kita H, Takada M, Nambu A.
    Eur J Neurosci; 2011 Nov 07; 34(9):1470-84. PubMed ID: 22034978
    [Abstract] [Full Text] [Related]

  • 13. Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease.
    Obeso JA, Rodríguez-Oroz MC, Benitez-Temino B, Blesa FJ, Guridi J, Marin C, Rodriguez M.
    Mov Disord; 2008 Nov 07; 23 Suppl 3():S548-59. PubMed ID: 18781672
    [Abstract] [Full Text] [Related]

  • 14. Dysfunction of the cortico-basal ganglia-cortical loop in a rat model of early parkinsonism is reversed by metabotropic glutamate receptor 5 antagonism.
    Oueslati A, Breysse N, Amalric M, Kerkerian-Le Goff L, Salin P.
    Eur J Neurosci; 2005 Dec 07; 22(11):2765-74. PubMed ID: 16324110
    [Abstract] [Full Text] [Related]

  • 15. Adenosine A(2A) receptor-mediated modulation of GABA and glutamate release in the output regions of the basal ganglia in a rodent model of Parkinson's disease.
    Ochi M, Shiozaki S, Kase H.
    Neuroscience; 2004 Dec 07; 127(1):223-31. PubMed ID: 15219684
    [Abstract] [Full Text] [Related]

  • 16. Mean-field modeling of the basal ganglia-thalamocortical system. II Dynamics of parkinsonian oscillations.
    van Albada SJ, Gray RT, Drysdale PM, Robinson PA.
    J Theor Biol; 2009 Apr 21; 257(4):664-88. PubMed ID: 19154745
    [Abstract] [Full Text] [Related]

  • 17. Altered function of glutamatergic cortico-striatal synapses causes output pathway abnormalities in a chronic model of parkinsonism.
    Warre R, Thiele S, Talwar S, Kamal M, Johnston TH, Wang S, Lam D, Lo C, Khademullah CS, Perera G, Reyes G, Sun XS, Brotchie JM, Nash JE.
    Neurobiol Dis; 2011 Mar 21; 41(3):591-604. PubMed ID: 20971190
    [Abstract] [Full Text] [Related]

  • 18. Differential expression and ser897 phosphorylation of striatal N-methyl-d-aspartate receptor subunit NR1 in animal models of Parkinson's disease.
    Betarbet R, Poisik O, Sherer TB, Greenamyre JT.
    Exp Neurol; 2004 May 21; 187(1):76-85. PubMed ID: 15081590
    [Abstract] [Full Text] [Related]

  • 19. Distinct changes in evoked and resting globus pallidus activity in early and late Parkinson's disease experimental models.
    Zold CL, Larramendy C, Riquelme LA, Murer MG.
    Eur J Neurosci; 2007 Sep 21; 26(5):1267-79. PubMed ID: 17767504
    [Abstract] [Full Text] [Related]

  • 20. Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease.
    Dunah AW, Wang Y, Yasuda RP, Kameyama K, Huganir RL, Wolfe BB, Standaert DG.
    Mol Pharmacol; 2000 Feb 21; 57(2):342-52. PubMed ID: 10648644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.